ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Estrogen and Progesterone API Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-11P17136
Home | Market Reports
Global Estrogen and Progesterone API Market Research Report 2024
BUY CHAPTERS

Global Estrogen and Progesterone API Market Research Report 2025

Code: QYRE-Auto-11P17136
Report
2025-12-23
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
EUROAPI
Pfizer CentreOne
GlaxoSmithKline PLC
TAPI
Axplora
Steroid Spa
Symbiotec Pharmalab
Hunan Yuxin Pharmaceutical

Estrogen and Progesterone API Market Size

The global market for Estrogen and Progesterone API was valued at US$ 489 million in the year 2024 and is projected to reach a revised size of US$ 733 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Estrogen and Progesterone API Market

Estrogen and Progesterone API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Estrogen and Progesterone API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Estrogen and Progesterone APIs refer to active pharmaceutical ingredients used to manufacture steroid hormone formulations for women. They are produced mainly through chemical or semi-synthetic processes, sometimes from converted phytosterols. Typical estrogen APIs include estradiol, ethinylestradiol and conjugated estrogens, while progesterone APIs include progesterone, norethisterone and medroxyprogesterone acetate. These APIs are applied in oral contraceptives, hormone replacement therapy, and treatments for menopausal symptoms and gynecological endocrine disorders. Quality requirements follow pharmacopeia standards, with strict control of purity, residual solvents and impurities, and manufacturing must comply with GMP.
In 2024, global sales of estrogen and progesterone raw materials reached 616.3 tons, with an average selling price of US$793/kg and a production capacity of approximately 1,600 tons. The industry's gross profit margin was above 40%. Cost structure: Direct materials accounted for approximately 60%, manufacturing costs approximately 28%, and labor costs approximately 12%. Industry chain: Upstream consists of starting materials and intermediates (chemical reagents, solvents, catalysts), while downstream comprises pharmaceutical manufacturers and the medical/end-user market.
Market Trends: The market growth is underpinned by clear demand drivers. The aging global population and rising awareness of women's health are increasing the need for hormone therapies addressing conditions like menopausal symptoms. The widespread adoption and accessibility of assisted reproductive technologies directly boost the consumption of related hormone APIs. Furthermore, the improvement of healthcare systems in emerging markets like Asia-Pacific offers new avenues for expansion. Technologically, the industry is moving towards greener and more efficient synthesis processes (e.g., enzymatic catalysis, continuous manufacturing) and deeper collaboration with complex drug delivery systems.
Growth Opportunities: Future opportunities lie in deepening existing demand and tapping into new markets. The need for precise and personalized treatments in areas such as menopause management, gynecological diseases, and assisted reproduction will foster demand for high-end APIs. The development of innovative drug delivery systems (e.g., transdermal patches) also opens new application pathways for APIs. Meanwhile, key producing countries like China are actively exploring global markets through supply chain regionalization and market diversification strategies to secure new growth.
Restraining Factors: The industry's progress faces several key obstacles. Stringent global regulations and complex product quality requirements present significant market entry and technological barriers. Safety concerns associated with hormone drugs and intense price competition following patent expiries continue to pressure profit margins. Additionally, the increasingly complex international trade environment and geopolitical factors introduce uncertainty to global supply chain stability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone API.
The Estrogen and Progesterone API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Estrogen and Progesterone API market comprehensively. Regional market sizes, concerning products by Type, by Application, by Hormone Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estrogen and Progesterone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Hormone Type and by regions.

Scope of Estrogen and Progesterone API Market Report

Report Metric Details
Report Name Estrogen and Progesterone API Market
Accounted market size in year US$ 489 million
Forecasted market size in 2031 US$ 733 million
CAGR 5.9%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Estrogens
  • Progestins
Segment by Hormone Type
  • Progesterone
  • Estradiol
  • Ethinylestradiol
  • Levonorgestrel
  • Megestrol
  • Other
Segment by Source
  • Natural Hormones
  • Synthetic Hormones
Segment by Application
  • Oral Preparation
  • Topical Preparations
  • Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer CentreOne, EUROAPI, GlaxoSmithKline, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical, Hunan Yuxin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Estrogen and Progesterone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Estrogen and Progesterone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Estrogen and Progesterone API Market growing?

Ans: The Estrogen and Progesterone API Market witnessing a CAGR of 5.9% during the forecast period 2026-2031.

What is the Estrogen and Progesterone API Market size in 2031?

Ans: The Estrogen and Progesterone API Market size in 2031 will be US$ 733 million.

Who are the main players in the Estrogen and Progesterone API Market report?

Ans: The main players in the Estrogen and Progesterone API Market are Pfizer CentreOne, EUROAPI, GlaxoSmithKline, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical, Hunan Yuxin Pharmaceutical

What are the Application segmentation covered in the Estrogen and Progesterone API Market report?

Ans: The Applications covered in the Estrogen and Progesterone API Market report are Oral Preparation, Topical Preparations, Injection

What are the Type segmentation covered in the Estrogen and Progesterone API Market report?

Ans: The Types covered in the Estrogen and Progesterone API Market report are Progesterone, Estradiol, Ethinylestradiol, Levonorgestrel, Megestrol, Other

1 Estrogen and Progesterone API Market Overview
1.1 Product Definition
1.2 Estrogen and Progesterone API by Type
1.2.1 Global Estrogen and Progesterone API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Estrogens
1.2.3 Progestins
1.3 Estrogen and Progesterone API by Hormone Type
1.3.1 Global Estrogen and Progesterone API Market Value Comparison by Hormone Type: 2024 VS 2031
1.3.2 Progesterone
1.3.3 Estradiol
1.3.4 Ethinylestradiol
1.3.5 Levonorgestrel
1.3.6 Megestrol
1.3.7 Other
1.4 Estrogen and Progesterone API by Source
1.4.1 Global Estrogen and Progesterone API Market Value Comparison by Source: 2024 VS 2031
1.4.2 Natural Hormones
1.4.3 Synthetic Hormones
1.5 Estrogen and Progesterone API by Application
1.5.1 Global Estrogen and Progesterone API Market Value by Application (2024 VS 2031)
1.5.2 Oral Preparation
1.5.3 Topical Preparations
1.5.4 Injection
1.6 Global Estrogen and Progesterone API Market Size Estimates and Forecasts
1.6.1 Global Estrogen and Progesterone API Revenue 2020-2031
1.6.2 Global Estrogen and Progesterone API Sales 2020-2031
1.6.3 Global Estrogen and Progesterone API Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Estrogen and Progesterone API Market Competition by Manufacturers
2.1 Global Estrogen and Progesterone API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Estrogen and Progesterone API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Estrogen and Progesterone API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Estrogen and Progesterone API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estrogen and Progesterone API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estrogen and Progesterone API, Product Type & Application
2.7 Global Key Manufacturers of Estrogen and Progesterone API, Date of Enter into This Industry
2.8 Global Estrogen and Progesterone API Market Competitive Situation and Trends
2.8.1 Global Estrogen and Progesterone API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Estrogen and Progesterone API Players Market Share by Revenue
2.8.3 Global Estrogen and Progesterone API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Estrogen and Progesterone API Market Scenario by Region
3.1 Global Estrogen and Progesterone API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Estrogen and Progesterone API Sales by Region: 2020-2031
3.2.1 Global Estrogen and Progesterone API Sales by Region: 2020-2025
3.2.2 Global Estrogen and Progesterone API Sales by Region: 2026-2031
3.3 Global Estrogen and Progesterone API Revenue by Region: 2020-2031
3.3.1 Global Estrogen and Progesterone API Revenue by Region: 2020-2025
3.3.2 Global Estrogen and Progesterone API Revenue by Region: 2026-2031
3.4 North America Estrogen and Progesterone API Market Facts & Figures by Country
3.4.1 North America Estrogen and Progesterone API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Estrogen and Progesterone API Sales by Country (2020-2031)
3.4.3 North America Estrogen and Progesterone API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Estrogen and Progesterone API Market Facts & Figures by Country
3.5.1 Europe Estrogen and Progesterone API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Estrogen and Progesterone API Sales by Country (2020-2031)
3.5.3 Europe Estrogen and Progesterone API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estrogen and Progesterone API Market Facts & Figures by Region
3.6.1 Asia Pacific Estrogen and Progesterone API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Estrogen and Progesterone API Sales by Region (2020-2031)
3.6.3 Asia Pacific Estrogen and Progesterone API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Estrogen and Progesterone API Market Facts & Figures by Country
3.7.1 Latin America Estrogen and Progesterone API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Estrogen and Progesterone API Sales by Country (2020-2031)
3.7.3 Latin America Estrogen and Progesterone API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Estrogen and Progesterone API Market Facts & Figures by Country
3.8.1 Middle East and Africa Estrogen and Progesterone API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Estrogen and Progesterone API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Estrogen and Progesterone API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estrogen and Progesterone API Sales by Type (2020-2031)
4.1.1 Global Estrogen and Progesterone API Sales by Type (2020-2025)
4.1.2 Global Estrogen and Progesterone API Sales by Type (2026-2031)
4.1.3 Global Estrogen and Progesterone API Sales Market Share by Type (2020-2031)
4.2 Global Estrogen and Progesterone API Revenue by Type (2020-2031)
4.2.1 Global Estrogen and Progesterone API Revenue by Type (2020-2025)
4.2.2 Global Estrogen and Progesterone API Revenue by Type (2026-2031)
4.2.3 Global Estrogen and Progesterone API Revenue Market Share by Type (2020-2031)
4.3 Global Estrogen and Progesterone API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Estrogen and Progesterone API Sales by Application (2020-2031)
5.1.1 Global Estrogen and Progesterone API Sales by Application (2020-2025)
5.1.2 Global Estrogen and Progesterone API Sales by Application (2026-2031)
5.1.3 Global Estrogen and Progesterone API Sales Market Share by Application (2020-2031)
5.2 Global Estrogen and Progesterone API Revenue by Application (2020-2031)
5.2.1 Global Estrogen and Progesterone API Revenue by Application (2020-2025)
5.2.2 Global Estrogen and Progesterone API Revenue by Application (2026-2031)
5.2.3 Global Estrogen and Progesterone API Revenue Market Share by Application (2020-2031)
5.3 Global Estrogen and Progesterone API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer CentreOne
6.1.1 Pfizer CentreOne Company Information
6.1.2 Pfizer CentreOne Description and Business Overview
6.1.3 Pfizer CentreOne Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer CentreOne Estrogen and Progesterone API Product Portfolio
6.1.5 Pfizer CentreOne Recent Developments/Updates
6.2 EUROAPI
6.2.1 EUROAPI Company Information
6.2.2 EUROAPI Description and Business Overview
6.2.3 EUROAPI Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 EUROAPI Estrogen and Progesterone API Product Portfolio
6.2.5 EUROAPI Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Estrogen and Progesterone API Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 TAPI
6.4.1 TAPI Company Information
6.4.2 TAPI Description and Business Overview
6.4.3 TAPI Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TAPI Estrogen and Progesterone API Product Portfolio
6.4.5 TAPI Recent Developments/Updates
6.5 Axplora
6.5.1 Axplora Company Information
6.5.2 Axplora Description and Business Overview
6.5.3 Axplora Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Axplora Estrogen and Progesterone API Product Portfolio
6.5.5 Axplora Recent Developments/Updates
6.6 Steroid SpA
6.6.1 Steroid SpA Company Information
6.6.2 Steroid SpA Description and Business Overview
6.6.3 Steroid SpA Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Steroid SpA Estrogen and Progesterone API Product Portfolio
6.6.5 Steroid SpA Recent Developments/Updates
6.7 Symbiotec Pharmalab
6.7.1 Symbiotec Pharmalab Company Information
6.7.2 Symbiotec Pharmalab Description and Business Overview
6.7.3 Symbiotec Pharmalab Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Symbiotec Pharmalab Estrogen and Progesterone API Product Portfolio
6.7.5 Symbiotec Pharmalab Recent Developments/Updates
6.8 Valdepharm (Fareva)
6.8.1 Valdepharm (Fareva) Company Information
6.8.2 Valdepharm (Fareva) Description and Business Overview
6.8.3 Valdepharm (Fareva) Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Valdepharm (Fareva) Estrogen and Progesterone API Product Portfolio
6.8.5 Valdepharm (Fareva) Recent Developments/Updates
6.9 Gonane Pharma
6.9.1 Gonane Pharma Company Information
6.9.2 Gonane Pharma Description and Business Overview
6.9.3 Gonane Pharma Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gonane Pharma Estrogen and Progesterone API Product Portfolio
6.9.5 Gonane Pharma Recent Developments/Updates
6.10 Aspen API
6.10.1 Aspen API Company Information
6.10.2 Aspen API Description and Business Overview
6.10.3 Aspen API Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aspen API Estrogen and Progesterone API Product Portfolio
6.10.5 Aspen API Recent Developments/Updates
6.11 Gedeon Richter
6.11.1 Gedeon Richter Company Information
6.11.2 Gedeon Richter Description and Business Overview
6.11.3 Gedeon Richter Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gedeon Richter Estrogen and Progesterone API Product Portfolio
6.11.5 Gedeon Richter Recent Developments/Updates
6.12 Zhejiang Xianju Pharmaceutical
6.12.1 Zhejiang Xianju Pharmaceutical Company Information
6.12.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.13 Humanwell Healthcare
6.13.1 Humanwell Healthcare Company Information
6.13.2 Humanwell Healthcare Description and Business Overview
6.13.3 Humanwell Healthcare Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Humanwell Healthcare Estrogen and Progesterone API Product Portfolio
6.13.5 Humanwell Healthcare Recent Developments/Updates
6.14 Hunan Norchem Pharmaceutical
6.14.1 Hunan Norchem Pharmaceutical Company Information
6.14.2 Hunan Norchem Pharmaceutical Description and Business Overview
6.14.3 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.14.5 Hunan Norchem Pharmaceutical Recent Developments/Updates
6.15 Zhejiang Xianju Xianle Pharmaceutical
6.15.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
6.15.2 Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.15.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
6.16 Hunan Yuxin Pharmaceutical
6.16.1 Hunan Yuxin Pharmaceutical Company Information
6.16.2 Hunan Yuxin Pharmaceutical Description and Business Overview
6.16.3 Hunan Yuxin Pharmaceutical Estrogen and Progesterone API Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hunan Yuxin Pharmaceutical Estrogen and Progesterone API Product Portfolio
6.16.5 Hunan Yuxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estrogen and Progesterone API Industry Chain Analysis
7.2 Estrogen and Progesterone API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estrogen and Progesterone API Production Mode & Process Analysis
7.4 Estrogen and Progesterone API Sales and Marketing
7.4.1 Estrogen and Progesterone API Sales Channels
7.4.2 Estrogen and Progesterone API Distributors
7.5 Estrogen and Progesterone API Customer Analysis
8 Estrogen and Progesterone API Market Dynamics
8.1 Estrogen and Progesterone API Industry Trends
8.2 Estrogen and Progesterone API Market Drivers
8.3 Estrogen and Progesterone API Market Challenges
8.4 Estrogen and Progesterone API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
EUROAPI
Pfizer CentreOne
GlaxoSmithKline PLC
TAPI
Axplora
Steroid Spa
Symbiotec Pharmalab
Hunan Yuxin Pharmaceutical
List of Tables
 Table 1. Global Estrogen and Progesterone API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Estrogen and Progesterone API Market Value by Hormone Type, (US$ Million) & (2024 VS 2031)
 Table 3. Global Estrogen and Progesterone API Market Value by Source, (US$ Million) & (2024 VS 2031)
 Table 4. Global Estrogen and Progesterone API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global Estrogen and Progesterone API Market Competitive Situation by Manufacturers in 2024
 Table 6. Global Estrogen and Progesterone API Sales (Tons) of Key Manufacturers (2020-2025)
 Table 7. Global Estrogen and Progesterone API Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global Estrogen and Progesterone API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global Estrogen and Progesterone API Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market Estrogen and Progesterone API Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of Estrogen and Progesterone API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of Estrogen and Progesterone API, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of Estrogen and Progesterone API, Product Type & Application
 Table 14. Global Key Manufacturers of Estrogen and Progesterone API, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Estrogen and Progesterone API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progesterone API as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Estrogen and Progesterone API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Estrogen and Progesterone API Sales by Region (2020-2025) & (Tons)
 Table 20. Global Estrogen and Progesterone API Sales Market Share by Region (2020-2025)
 Table 21. Global Estrogen and Progesterone API Sales by Region (2026-2031) & (Tons)
 Table 22. Global Estrogen and Progesterone API Sales Market Share by Region (2026-2031)
 Table 23. Global Estrogen and Progesterone API Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global Estrogen and Progesterone API Revenue Market Share by Region (2020-2025)
 Table 25. Global Estrogen and Progesterone API Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global Estrogen and Progesterone API Revenue Market Share by Region (2026-2031)
 Table 27. North America Estrogen and Progesterone API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America Estrogen and Progesterone API Sales by Country (2020-2025) & (Tons)
 Table 29. North America Estrogen and Progesterone API Sales by Country (2026-2031) & (Tons)
 Table 30. North America Estrogen and Progesterone API Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America Estrogen and Progesterone API Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe Estrogen and Progesterone API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe Estrogen and Progesterone API Sales by Country (2020-2025) & (Tons)
 Table 34. Europe Estrogen and Progesterone API Sales by Country (2026-2031) & (Tons)
 Table 35. Europe Estrogen and Progesterone API Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe Estrogen and Progesterone API Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific Estrogen and Progesterone API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific Estrogen and Progesterone API Sales by Region (2020-2025) & (Tons)
 Table 39. Asia Pacific Estrogen and Progesterone API Sales by Region (2026-2031) & (Tons)
 Table 40. Asia Pacific Estrogen and Progesterone API Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific Estrogen and Progesterone API Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Estrogen and Progesterone API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America Estrogen and Progesterone API Sales by Country (2020-2025) & (Tons)
 Table 44. Latin America Estrogen and Progesterone API Sales by Country (2026-2031) & (Tons)
 Table 45. Latin America Estrogen and Progesterone API Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Estrogen and Progesterone API Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa Estrogen and Progesterone API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa Estrogen and Progesterone API Sales by Country (2020-2025) & (Tons)
 Table 49. Middle East and Africa Estrogen and Progesterone API Sales by Country (2026-2031) & (Tons)
 Table 50. Middle East and Africa Estrogen and Progesterone API Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Estrogen and Progesterone API Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global Estrogen and Progesterone API Sales (Tons) by Type (2020-2025)
 Table 53. Global Estrogen and Progesterone API Sales (Tons) by Type (2026-2031)
 Table 54. Global Estrogen and Progesterone API Sales Market Share by Type (2020-2025)
 Table 55. Global Estrogen and Progesterone API Sales Market Share by Type (2026-2031)
 Table 56. Global Estrogen and Progesterone API Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global Estrogen and Progesterone API Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global Estrogen and Progesterone API Revenue Market Share by Type (2020-2025)
 Table 59. Global Estrogen and Progesterone API Revenue Market Share by Type (2026-2031)
 Table 60. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2020-2025)
 Table 61. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2026-2031)
 Table 62. Global Estrogen and Progesterone API Sales (Tons) by Application (2020-2025)
 Table 63. Global Estrogen and Progesterone API Sales (Tons) by Application (2026-2031)
 Table 64. Global Estrogen and Progesterone API Sales Market Share by Application (2020-2025)
 Table 65. Global Estrogen and Progesterone API Sales Market Share by Application (2026-2031)
 Table 66. Global Estrogen and Progesterone API Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global Estrogen and Progesterone API Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global Estrogen and Progesterone API Revenue Market Share by Application (2020-2025)
 Table 69. Global Estrogen and Progesterone API Revenue Market Share by Application (2026-2031)
 Table 70. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2020-2025)
 Table 71. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2026-2031)
 Table 72. Pfizer CentreOne Company Information
 Table 73. Pfizer CentreOne Description and Business Overview
 Table 74. Pfizer CentreOne Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 75. Pfizer CentreOne Estrogen and Progesterone API Product
 Table 76. Pfizer CentreOne Recent Developments/Updates
 Table 77. EUROAPI Company Information
 Table 78. EUROAPI Description and Business Overview
 Table 79. EUROAPI Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 80. EUROAPI Estrogen and Progesterone API Product
 Table 81. EUROAPI Recent Developments/Updates
 Table 82. GlaxoSmithKline Company Information
 Table 83. GlaxoSmithKline Description and Business Overview
 Table 84. GlaxoSmithKline Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 85. GlaxoSmithKline Estrogen and Progesterone API Product
 Table 86. GlaxoSmithKline Recent Developments/Updates
 Table 87. TAPI Company Information
 Table 88. TAPI Description and Business Overview
 Table 89. TAPI Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 90. TAPI Estrogen and Progesterone API Product
 Table 91. TAPI Recent Developments/Updates
 Table 92. Axplora Company Information
 Table 93. Axplora Description and Business Overview
 Table 94. Axplora Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 95. Axplora Estrogen and Progesterone API Product
 Table 96. Axplora Recent Developments/Updates
 Table 97. Steroid SpA Company Information
 Table 98. Steroid SpA Description and Business Overview
 Table 99. Steroid SpA Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 100. Steroid SpA Estrogen and Progesterone API Product
 Table 101. Steroid SpA Recent Developments/Updates
 Table 102. Symbiotec Pharmalab Company Information
 Table 103. Symbiotec Pharmalab Description and Business Overview
 Table 104. Symbiotec Pharmalab Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 105. Symbiotec Pharmalab Estrogen and Progesterone API Product
 Table 106. Symbiotec Pharmalab Recent Developments/Updates
 Table 107. Valdepharm (Fareva) Company Information
 Table 108. Valdepharm (Fareva) Description and Business Overview
 Table 109. Valdepharm (Fareva) Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 110. Valdepharm (Fareva) Estrogen and Progesterone API Product
 Table 111. Valdepharm (Fareva) Recent Developments/Updates
 Table 112. Gonane Pharma Company Information
 Table 113. Gonane Pharma Description and Business Overview
 Table 114. Gonane Pharma Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 115. Gonane Pharma Estrogen and Progesterone API Product
 Table 116. Gonane Pharma Recent Developments/Updates
 Table 117. Aspen API Company Information
 Table 118. Aspen API Description and Business Overview
 Table 119. Aspen API Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 120. Aspen API Estrogen and Progesterone API Product
 Table 121. Aspen API Recent Developments/Updates
 Table 122. Gedeon Richter Company Information
 Table 123. Gedeon Richter Description and Business Overview
 Table 124. Gedeon Richter Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 125. Gedeon Richter Estrogen and Progesterone API Product
 Table 126. Gedeon Richter Recent Developments/Updates
 Table 127. Zhejiang Xianju Pharmaceutical Company Information
 Table 128. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 129. Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 130. Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Product
 Table 131. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 132. Humanwell Healthcare Company Information
 Table 133. Humanwell Healthcare Description and Business Overview
 Table 134. Humanwell Healthcare Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 135. Humanwell Healthcare Estrogen and Progesterone API Product
 Table 136. Humanwell Healthcare Recent Developments/Updates
 Table 137. Hunan Norchem Pharmaceutical Company Information
 Table 138. Hunan Norchem Pharmaceutical Description and Business Overview
 Table 139. Hunan Norchem Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 140. Hunan Norchem Pharmaceutical Estrogen and Progesterone API Product
 Table 141. Hunan Norchem Pharmaceutical Recent Developments/Updates
 Table 142. Zhejiang Xianju Xianle Pharmaceutical Company Information
 Table 143. Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
 Table 144. Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 145. Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Product
 Table 146. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
 Table 147. Hunan Yuxin Pharmaceutical Company Information
 Table 148. Hunan Yuxin Pharmaceutical Description and Business Overview
 Table 149. Hunan Yuxin Pharmaceutical Estrogen and Progesterone API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 150. Hunan Yuxin Pharmaceutical Estrogen and Progesterone API Product
 Table 151. Hunan Yuxin Pharmaceutical Recent Developments/Updates
 Table 152. Key Raw Materials Lists
 Table 153. Raw Materials Key Suppliers Lists
 Table 154. Estrogen and Progesterone API Distributors List
 Table 155. Estrogen and Progesterone API Customers List
 Table 156. Estrogen and Progesterone API Market Trends
 Table 157. Estrogen and Progesterone API Market Drivers
 Table 158. Estrogen and Progesterone API Market Challenges
 Table 159. Estrogen and Progesterone API Market Restraints
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources
 Table 163. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Estrogen and Progesterone API
 Figure 2. Global Estrogen and Progesterone API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Estrogen and Progesterone API Market Share by Type: 2024 & 2031
 Figure 4. Estrogens Product Picture
 Figure 5. Progestins Product Picture
 Figure 6. Global Estrogen and Progesterone API Market Value by Hormone Type, (US$ Million) & (2020-2031)
 Figure 7. Global Estrogen and Progesterone API Market Share by Hormone Type: 2024 VS 2031
 Figure 8. Progesterone Product Picture
 Figure 9. Estradiol Product Picture
 Figure 10. Ethinylestradiol Product Picture
 Figure 11. Levonorgestrel Product Picture
 Figure 12. Megestrol Product Picture
 Figure 13. Other Product Picture
 Figure 14. Global Estrogen and Progesterone API Market Value by Source, (US$ Million) & (2020-2031)
 Figure 15. Global Estrogen and Progesterone API Market Share by Source: 2024 VS 2031
 Figure 16. Natural Hormones Product Picture
 Figure 17. Synthetic Hormones Product Picture
 Figure 18. Global Estrogen and Progesterone API Market Value by Application (2020-2031) & (US$ Million)
 Figure 19. Global Estrogen and Progesterone API Market Share by Application: 2024 & 2031
 Figure 20. Oral Preparation
 Figure 21. Topical Preparations
 Figure 22. Injection
 Figure 23. Global Estrogen and Progesterone API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 24. Global Estrogen and Progesterone API Market Size (2020-2031) & (US$ Million)
 Figure 25. Global Estrogen and Progesterone API Sales (2020-2031) & (Tons)
 Figure 26. Global Estrogen and Progesterone API Average Price (US$/Kg) & (2020-2031)
 Figure 27. Estrogen and Progesterone API Report Years Considered
 Figure 28. Estrogen and Progesterone API Sales Share by Manufacturers in 2024
 Figure 29. Global Estrogen and Progesterone API Revenue Share by Manufacturers in 2024
 Figure 30. Global 5 and 10 Largest Estrogen and Progesterone API Players: Market Share by Revenue in Estrogen and Progesterone API in 2024
 Figure 31. Estrogen and Progesterone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 32. Global Estrogen and Progesterone API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 33. North America Estrogen and Progesterone API Sales Market Share by Country (2020-2031)
 Figure 34. North America Estrogen and Progesterone API Revenue Market Share by Country (2020-2031)
 Figure 35. United States Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Canada Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Europe Estrogen and Progesterone API Sales Market Share by Country (2020-2031)
 Figure 38. Europe Estrogen and Progesterone API Revenue Market Share by Country (2020-2031)
 Figure 39. Germany Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. France Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. U.K. Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Italy Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Russia Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Asia Pacific Estrogen and Progesterone API Sales Market Share by Region (2020-2031)
 Figure 45. Asia Pacific Estrogen and Progesterone API Revenue Market Share by Region (2020-2031)
 Figure 46. China Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Japan Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. South Korea Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. India Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Australia Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. China Taiwan Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Southeast Asia Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Latin America Estrogen and Progesterone API Sales Market Share by Country (2020-2031)
 Figure 54. Latin America Estrogen and Progesterone API Revenue Market Share by Country (2020-2031)
 Figure 55. Mexico Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Brazil Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Argentina Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Colombia Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Estrogen and Progesterone API Sales Market Share by Country (2020-2031)
 Figure 60. Middle East and Africa Estrogen and Progesterone API Revenue Market Share by Country (2020-2031)
 Figure 61. Turkey Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 62. Saudi Arabia Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 63. UAE Estrogen and Progesterone API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 64. Global Sales Market Share of Estrogen and Progesterone API by Type (2020-2031)
 Figure 65. Global Revenue Market Share of Estrogen and Progesterone API by Type (2020-2031)
 Figure 66. Global Estrogen and Progesterone API Price (US$/Kg) by Type (2020-2031)
 Figure 67. Global Sales Market Share of Estrogen and Progesterone API by Application (2020-2031)
 Figure 68. Global Revenue Market Share of Estrogen and Progesterone API by Application (2020-2031)
 Figure 69. Global Estrogen and Progesterone API Price (US$/Kg) by Application (2020-2031)
 Figure 70. Estrogen and Progesterone API Value Chain
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Progesterone API Market Research Report 2025
Global Estrogen API Market Research Report 2024
Global β Estradiol API Market Research Report 2024
Global Hydroxyprogesterone Caproate API Market Research Report 2024
Global Eplerenone API Market Research Report 2025
Global Mifepristone API Market Research Report 2025
Global Estrogen Receptor Market Research Report 2024
Global Dydrogesterone API Market Research Report 2024
Global Progesterone Receptor Agonist Market Research Report 2024
Global Progesterone Injection Market Research Report 2024
Global Ethinylestradiol API Market Research Report 2025
Global Hydrocortisone API Market Research Report 2024
Steroid APIs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estrogen Receptor Beta Market Research Report 2024
Global Exemestane API Market Research Report 2024
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Steroid Hormones Market Research Report 2025
Global Estradiol Valerate Market Research Report 2025
Global Prednisolone API Market Research Report 2025
Global Sex Hormones API Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions